ATE74000T1 - Dihydroergotamin-(d.h.e.)-tablette des typs hydrophile matrix und verfahren zu ihrer herstellung. - Google Patents

Dihydroergotamin-(d.h.e.)-tablette des typs hydrophile matrix und verfahren zu ihrer herstellung.

Info

Publication number
ATE74000T1
ATE74000T1 AT88400340T AT88400340T ATE74000T1 AT E74000 T1 ATE74000 T1 AT E74000T1 AT 88400340 T AT88400340 T AT 88400340T AT 88400340 T AT88400340 T AT 88400340T AT E74000 T1 ATE74000 T1 AT E74000T1
Authority
AT
Austria
Prior art keywords
dihydroergotamine
tablet
type
hydrophilic matrix
production
Prior art date
Application number
AT88400340T
Other languages
English (en)
Inventor
Michel Sournac
Joel Bougaret
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE74000T1 publication Critical patent/ATE74000T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT88400340T 1987-02-18 1988-02-16 Dihydroergotamin-(d.h.e.)-tablette des typs hydrophile matrix und verfahren zu ihrer herstellung. ATE74000T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8702076A FR2610827B1 (fr) 1987-02-18 1987-02-18 Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
EP88400340A EP0280613B1 (de) 1987-02-18 1988-02-16 Dihydroergotamin-(D.H.E.)-Tablette des Typs hydrophile Matrix und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE74000T1 true ATE74000T1 (de) 1992-04-15

Family

ID=9348044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88400340T ATE74000T1 (de) 1987-02-18 1988-02-16 Dihydroergotamin-(d.h.e.)-tablette des typs hydrophile matrix und verfahren zu ihrer herstellung.

Country Status (7)

Country Link
EP (1) EP0280613B1 (de)
JP (1) JPS63203617A (de)
AT (1) ATE74000T1 (de)
CA (1) CA1340660C (de)
DE (1) DE3869443D1 (de)
ES (1) ES2037254T3 (de)
FR (1) FR2610827B1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
HRP20010700B1 (hr) 1999-03-31 2011-01-31 Janssen Pharmaceutica N.V. Prezelatinizirani skrob u formulaciji s kontroliranim otpustanjem
RU2162324C1 (ru) * 1999-11-23 2001-01-27 Аметов Александр Сергеевич Способ фармакологического лечения психогенной эректильной дисфункции
RU2256454C2 (ru) * 1999-12-03 2005-07-20 Полишем С.А. Способы получения фармацевтических композиций алкалоидов спорыньи с пролонгированным действием, характеризующихся улучшенной биодоступностью, и содержащие указанные алкалоиды композиции
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4652442A (en) * 1983-07-05 1987-03-24 Arcana Chem. Pharm. Fabrik Gesellschaft M.B.H. Process of producing a sustained release preparation containing indomethacin or niomethacin
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
US4608248A (en) * 1985-11-08 1986-08-26 Warner-Lambert Company Process for time-controlled release of active ingredients

Also Published As

Publication number Publication date
CA1340660C (fr) 1999-07-20
JPS63203617A (ja) 1988-08-23
DE3869443D1 (de) 1992-04-30
FR2610827B1 (fr) 1991-09-13
EP0280613B1 (de) 1992-03-25
EP0280613A1 (de) 1988-08-31
FR2610827A1 (fr) 1988-08-19
ES2037254T3 (es) 1993-06-16

Similar Documents

Publication Publication Date Title
ZA907338B (en) Thienylcarboxylates of amino alcohols
EP0274392A3 (de) Relationelles Datenbanksystem
GB8820230D0 (en) Battery & battery receptacle arrangement
MX174467B (es) 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
CA2133464A1 (en) Apparatus and method for holding a medical instrument
DE3850245D1 (de) Tintengeberanordnung und deren herstellung.
AU3917489A (en) Memory enhancing-r-n-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides
FI902166A0 (fi) Anvaendning kakaopulver foer foerbaettring av smaken i tuggummis syntetiska grundaemne. pct-akemus 85:pct nro 86:us89/03724 pvm 93:28.08.89 (93h:vvkkpp)
AU2930889A (en) Pharmaceutical preparation for treating immunodeficiency conditions
ATE74000T1 (de) Dihydroergotamin-(d.h.e.)-tablette des typs hydrophile matrix und verfahren zu ihrer herstellung.
AU8258987A (en) 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use
DE3679883D1 (de) Trisimide von allyl- oder methallyl-substituierten bicyclo(2.2.1)hept-5-en-2,3-dicarbonsaeureimiden und deren verwendung.
CA2037150A1 (en) Retinoids
DE68907841D1 (de) 1,1-dicyclohexylcycloalkanderivate, verfahren zu ihrer herstellung und diese enthaltende kraftuebertragungsfluessigkeit.
AU2374988A (en) Anxiolytic-r-n-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides
HUT46838A (en) Pesticide compositions containing 2,5-bis-pyridyl-1,3,4-thiadiazol derivatives as active components and process for producing the active components
GR3007701T3 (de)
FI872269A7 (fi) Makeisissa käytettävä kumimainen aine.
DE58903565D1 (de) 1,2-naphthochinon-2-diazid-sulfonsaeureamide und lichtempfindliche gemische, die diese enthalten.
EP0367598A3 (en) Novel process for the production of 4,6-dimethyl-7-hydroxynonan-3-one
HUT48868A (en) Fungicides comprising n,n'-diacylaminals and process for producing the active ingredients
AU623386B2 (en) 1-dimethylcarbamoyl-3-substituted-5-substituted-1h-1,2,4- triazoles
JPS6440281A (en) Wrench
Ermakova Study of flexibility of thinking in children
MacKinnon Tool and weapon-the double axe in the Aegean; an examination of the manufacture and possible functions of the double axe in the Aegean, prior to 1000 BC.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties